Group

Lung cancer kills more people than colon, breast, and prostate cancer combined. But what if a computer could spot it years before you felt a thing – and with remarkable accuracy?

HISTORY / ORIGIN

For decades, lung cancer screening relied on the naked eye and a radiologist's expertise. Low-dose CT (LDCT) scans became the standard, but interpreting them was time‑consuming and prone to human error. The game changed in the early 2020s when AI-powered software began entering clinical practice. The FDA cleared several AI programs for lung cancer screening, and in February 2026, a major milestone was reached: the FDA granted 510(k) clearance to eyonis® LCS, the first end‑to‑end AI device that both detects and characterizes lung cancer in a single product. Today, the global lung cancer screening software market is projected to grow at nearly 18% annually through 2031, driven by advancements in artificial intelligence and rising health awareness.

TYPES OF LUNG CANCER SCREENING SOFTWARE

Computer-Aided Detection/Diagnosis (CADe/CADx) – Analyzes LDCT scans to flag suspicious nodules and assign a malignancy risk score. Examples: eyonis® LCS, AVIEW LCS, Veolity Lung CAD.

Clinical Decision Support (CDS) Tools – Helps primary care doctors identify who qualifies for screening, often integrating with electronic health records. The Lung Cancer Screening Guide app, for example, is built around ACR Lung‑RADS v2022.

Risk Prediction Models – Uses AI to predict future lung cancer risk from a single LDCT scan, going beyond just age and smoking history. Sybil is one such model.

Integrated Screening Management Platforms – All-in-one solutions that handle patient tracking, reporting, compliance, and data management – from enrollment all the way to follow‑up.

MATERIALS / KEY FEATURES

What makes this software so powerful? It's all in the algorithms and integration:

Deep learning models – Trained on thousands of CT scans to recognize subtle patterns invisible to the human eye.

Malignancy scoring – Assigns a risk score to each nodule, helping radiologists prioritize the most urgent cases.

Volumetric growth analysis – Tracks nodule size over time to detect dangerous growth.

Seamless workflow integration – Plugs directly into existing hospital imaging systems (PACS) and electronic health records.

Cloud‑based deployment – Enables remote access, tele‑radiology, and easy scalability.

BENEFITS / WHY CHOOSE AI‑POWERED SCREENING SOFTWARE

✅ Earlier detection, better survival – Stage 1 lung cancer caught through screening has ~80% long‑term survival, compared to just ~15% when detected after symptoms appear.

✅ Reduces radiologist workload – AI can cut interpretation time by up to 26%, allowing doctors to focus on the most complex cases.

✅ Minimizes human error – Algorithms automatically detect and characterize nodules with high sensitivity, reducing oversight.

✅ Cuts false positives – High specificity means fewer unnecessary follow‑up procedures and less patient anxiety. One FDA‑cleared system reports a false positive rate of just one per 1,000 exams.

✅ Expands access to screening – Cloud‑based solutions allow specialists to review scans remotely, benefiting underserved and rural areas.

CARE TIPS / USAGE TIPS

Choose FDA‑cleared or CE‑marked software – Regulatory approval ensures the product has been rigorously validated for safety and effectiveness.

Ensure seamless PACS/EHR integration – The software should fit into your existing workflow, not create extra steps.

Remember: AI assists, not replaces – Radiologist oversight remains essential. The software is a decision‑support tool, not a standalone diagnostician.

Stay updated on Lung‑RADS – The latest version (v2022) includes new modifiers for incidental findings. Ensure your software aligns with current guidelines.

Consider cloud‑based solutions – They offer scalability, automatic updates, and remote access – especially valuable for multi‑site screening programs.

ENGAGEMENT QUESTION

💬 Have you or a loved one benefited from lung cancer screening – or do you work with AI software in radiology? What's your take on AI helping catch cancer earlier? Share your thoughts or questions below.